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Abstract
The genus Shigella infects human gut epithelial cells to cause diarrhea and gastrointestinal disorders. Like many other Gram-
negative bacterial pathogens, the virulence of Shigella spp. relies on a conserved type three secretion system that delivers
a handful of effector proteins into host cells to manipulate various host cell physiology. However, many of the Shigella type
III effectors remain functionally uncharacterized. Here we observe that OspG, one of the Shigella effectors, interacted with
ubiquitin conjugates and poly-ubiquitin chains of either K48 or K63 linkage in eukaryotic host cells. Purified OspG protein
formed a stable complex with ubiquitin but showed no interactions with other ubiquitin-like proteins. OspG binding to
ubiquitin required the carboxyl terminal helical region in OspG and the canonical I44-centered hydrophobic surface in
ubiquitin. OspG and OspG-homologous effectors, NleH1/2 from enteropathogenic E coli (EPEC), contain sub-domains I-VII of
eukaryotic serine/threonine kinase. GST-tagged OspG and NleH1/2 could undergo autophosphorylation, the former of
which was significantly stimulated by ubiquitin binding. Ubiquitin binding was also required for OspG functioning in
attenuating host NF-kB signaling. Our data illustrate a new mechanism that bacterial pathogen like Shigella exploits
ubiquitin binding to activate its secreted virulence effector for its functioning in host eukaryotic cells.
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Introduction
Shigella spp. are Gram-negative bacterial pathogens whose
infection causes a spectrum of symptoms ranging from watery
diarrhea to severe dysentery [1]. Shigella harbors a 220-kb
virulence plasmid that is essential for successful infection [2]. This
plasmid encodes a specialized protein secretion apparatus called
the type three secretion system as well as more than a dozen of
type III-secreted effector proteins. Like in many other Gram-
negative bacterial pathogens, effector secreted by Shigella type III
secretion system function to facilitate infection, bacterial survival
and replication [3]. Studies in the past 20 years have shown that
type III secreted effectors can target multiple host cellular
processes such as innate immunity, actin cytoskeleton dynamics
and membrane trafficking [3,4]. In Shigella infection, the OspF
effector functions as a novel MAPK phosphothreonine lyase to
irreversibly inactivate mitogen-activated protein kinase (MAPK)
[5] and downregulate host inflammatory responses [6,7]. IpgB1/2
are guanine-nucleotide exchange factors (GEFs) and preferentially
activate small GTPase Rac1 and RhoA, respectively, to promote
Shigella invasion of host epithelial cells [8,9,10]. The VirA effector
is a novel TBC-like GTPase-activating protein (GAP), which
inactivates host Rab1 and contributes to Shigella escape from host
autophagy [11]. Expression of these Shigella effectors is under
sophisticated genetic regulation by temperature and contact host
cell contact. However, little is known about the regulation of
effector biochemical activities.
Protein ubiquitination critically controls nearly all aspects of
eukaryotic cellular processes including cell cycle progression, gene
transcription, various signal transduction pathways [12]. Ubiqui-
tination involves a three-enzyme cascade composed of ubiquitin-
activating enzyme, ubiquitin-conjugating enzyme and ubiquitin
ligase. In the third step, ubiquitin ligase catalyzes ubiquitin transfer
from the ubiquitin-conjugating enzyme onto a lysine side chain in
the substrate or another ubiquitin linked through an isopeptide
bond linkage. The latter generates either free ubiquitin chains or
ubiquitin chains attached to a substrate protein. Ubiquitin
conjugation onto one of the seven lysines in another ubiquitin
results in formation of ubiquitin chains with different linkages that
often confer different fates on the substrate protein [13]. The
ubiquitin system is frequently hijacked by bacterial pathogens
[14,15], and bacterial type III effectors can even directly
deamidate ubiquitin to paralyze its chain formation activity [16].
In the case of Shigella infection, the OspI effector deamidates an
ubiquitin-conjugating enzyme Ubc13 that is dedicated to form
K63-linked ubiquitin chains to dampen host NF-kB-mediated
inflammatory response [17]. Shigella also harbors a group of
effectors called IpaHs that define a third class of ubiquitin ligases
structurally distinct from eukaryotic HECT- and RING-domain
ubiquitin ligases [18,19,20]. IpaHs have also been implicated in
tuning the host inflammatory responses [21].
OspG is another Shigella type III effector. OspG was firstly
identified from the supernatant of Shigella flexneri DipaBCDA strain
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induced only after activation of the type three secretion apparatus,
suggesting its function at a later stage during Shigella infection [23].
OspG shares sequence similarity to mammalian serine/threonine
protein kinase and may interfere with innate immune responses by
targeting host ubiquitin-conjugating enzyme [24]. However, the
biochemical mechanism and regulation of OspG function remains
largely unknown.
In this work, we discover that OspG binds to free ubiquitin,
poly-ubiquitin chains as well as ubiquitin-conjugated proteins with
high affinity and specificity. We further demonstrate that OspG
binding to ubiquitin is mediated by the canonical I44-centered
hydrophobic surface in ubiquitin and requires a unique carboxyl
terminal helix in OspG. Ubiquitin binding significantly stimulates
the kinase activity of OspG, shown by evidently increased
autophosphorylation and intrinsic ATP hydrolysis activity. Ubi-
quitin binding is also required for OspG functioning in attenuating
host innate immune NF-kB signaling. Our data provide the first
example that bacterial effectors can make use of interaction with
host ubiquitin to activate itself.
Results
OspG Directly Binds to Polyubiquitin Conjugates
To search for possible OspG-interacting proteins related to
ubiquitination, purified GST-tagged OspG protein (GST-OspG)
was immobilized onto glutathione beads and incubated with
lysates of intact 293T cells or 293T cells pretreated with the
proteasome inhibitor MG132. Proteins retained on the beads were
then subjected to reducing SDS-PAGE and anti-ubiquitin (P4D1)
Western blotting analysis. Unexpectedly, we found that GST-
OspG, but not GST alone, could efficiently pull down a large
amount of polyubiquitinated proteins from intact 293T cell lysates,
as shown by the heavy smear signals recognized by the anti-
ubiquitin antibody (Fig. 1A). When cells were pretreated with
MG132 to increase the level of polyubiquitinated proteins, the
amounts of polyubiquitinated species precipitated by GST-OspG
were also significantly increased and such effects were not
observed with pulldown assays performed with GST protein alone
(Fig. 1A). These data suggest that OspG can specifically bind to
polyubiquitinated proteins in eukaryotic host cells.
As mentioned earlier, polyubiquitin chains with different
linkages are associated with different functions. K48-linked
ubiquitin chain is established in signaling conjugated substrates
for proteasomal degradation while the other prevalent K63
ubiquitin chain regulates the function or activity of the target
substrate. To examine whether OspG prefers to bind ubiquitin
chains with a particular linkage, His6-tagged ubiquitin chains
(Ub2-4) of either K48 or K63 linkage were incubated with GST or
GST-OspG. Consistent with the increased precipitation of
polyubiquitinated proteins by GST-OspG from MG132-treated
cells, GST-OspG, but not GST alone, was found to be efficiently
precipitated by K48-linked ubiquitin chains (Fig. 1B). Notably,
K63-linked ubiquitin chains (Ub2-7) could also specifically pull
down GST-OspG with efficiency comparable to that observed
K48 ubiquitin chains (Fig. 1C). These data demonstrate that
OspG can directly bind polyubiquitin chains of either K48 or K63
linkage and further indicate that OspG may modulate host
ubiquitin signaling that is not limited to proteasomal degradation.
OspG Directly Binds to Ubiquitin, but not Other
Ubiquitin-like Proteins
One interpretation accounting for OspG binding to both K48-
and K63-linked ubiquitin chains is that OspG may bind to the
monomer form of free ubiquitin, which was missed in the previous
cell-lysate pulldown assay because free ubiquitin ran out of the
12% SDS-PAGE gel used in that assay. To this end, samples of
GST-OspG pulldown performed with 293T cell lysates were re-
examined by Western blotting analysis using 4–20% gradient gel.
As shown in Fig. 1D, GST-OspG did precipitate free ubiquitin
more efficiently than the polyubiquitin-conjugated proteins. As
a control, no binding between ubiquitin and GST alone was
observed in this assay.
To confirm the direct interaction between OspG and ubiquitin,
purified His6- OspG was used to pull down recombinant GST and
GST-ubiquitin. Only GST-ubiquitin was precipitated by His6-
OspG and the binding appeared to be highly robust (Fig. 2A). In
eukaryotes, there are a large number of ubiquitin-binding modules
that confer diverse regulations of ubiquitin signaling. Most of these
ubiquitin-binding proteins recognize a critical conserved region on
ubiquitin, the I44-centered hydrophobic patch [25,26]. Interest-
ingly, when I44 of ubiquitin was mutated into Ala, precipitation of
this mutant form of ubiquitin by OspG was not observed (Fig. 2A).
This result indicates that OspG, similar to most ubiquitin-binding
modules in the host, also recognizes the canonical I44 surface of
ubiquitin to achieve high-affinity interaction.
Ubiquitin-like proteins (UBL proteins), such as SUMO and
LC3, share a three-dimensional structural fold with ubiquitin.
These UBLs can be conjugated onto target proteins through
a similar enzymatic cascade, which critically regulates many
cellular processes, including transcription, DNA repair, signal
transduction, autophagy and cell-cycle control [27,28]. To test
whether OspG can interact with other UBLs, His6-OspG was
used to pull down GST-SUMO1 and GST-LC3, but no
interaction was observed. This result suggests that OspG
selectively binds to ubiquitin among the UBL-family members
(Fig. 2A).
The interaction between OspG and ubiquitin was further tested
by elution on a gel filtration column. Purified OspG (23.6 kDa)
and ubiquitin (12.1 kDa), when loaded onto the column separate-
ly, were eluted at the volume corresponding to the molecular
weight of their monomeric forms (Fig. 2B). When OspG was
mixed with excess ubiquitin and the mixtures were loaded onto the
same column, a complex species eluted earlier than OspG and
ubiquitin alone appeared (Fig. 2B). The , 10.5 ml elution volume
of this species corresponds to roughly , 50 kDa for a globular
protein, suggesting a possible 1:1 stoichiometry for OspG and
ubiquitin binding. Further SDS-PAGE analysis of each fraction
confirmed the co-elution of OspG and ubiquitin as well as the
roughly estimated 1:1 OspG-ubiquitin complex (Fig. 2C).
Both the Carboxyl Terminus and the Kinase-like Domain
of OspG are Required for Ubiquitin Binding
OspG is a small-size protein with only 196 amino acids and its
sequence from residue 24 to 160 exhibits confident similarities to
sub-domains I to VII of eukaryotic serine/threonine kinase (Fig. 3A
and Fig. 4). The extreme carboxyl terminus (residues 161–196),
predicted to form an a helix, does not show any sequence
similarity to known proteins. The fact that no classical ubiquitin-
binding domains or motifs could be identified in OspG indicates
a novel ubiquitin-binding mode and also promoted us to further
investigate its ubiquitin binding mechanism. Truncation of the
amino terminal 21 residues preceding the putative kinase domain
did not affect OspG binding to ubiquitin in the in vitro pulldown
assay (Fig. 3B). Notably, removal of the extreme carboxyl terminal
26 residues in OspG completely abolished its interaction with
ubiquitin (Fig. 3C), suggesting that the carboxyl terminal region
following the kinase-like domain in OspG is essential for ubiquitin
Ubiquitin Binding Activates OspG Kinase Activity
PLOS ONE | www.plosone.org 2 February 2013 | Volume 8 | Issue 2 | e57558Figure 1. High-affinity binding between OspG and ubiquitin conjugates, poly-ubiquitin chains and free ubiquitin. (A) Pulldown of
ubiquitin-conjugated proteins by purified GST-OspG. Glutathione-Sepharose beads coated with GST-OspG or GST alone were incubated with lysates
of intact 293T cells or MG132- treated 293T cells. Proteins retained on the beads were eluted with SDS loading buffer and separated onto12% SDS-
PAGE gels. Shown on the left are anti-ubiquitin immunoblots and on the right are Coomassie blue staining of GST or GST-OspG proteins present on
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region abolishedOspG binding to ubiquitin (Fig. 3C), suggesting
the importance of these two residues. Furthermore, when the
carboxyl terminal 26, 31, or 35 residues were artificially fused to
GST protein and the fusion proteins were assayed for co-
precipitation by ubiquitin, none of the three chimeric proteins
were capable of binding to ubiquitin (Fig. 3D). These data suggest
that the carboxyl terminal helical region in OspG is essential but
not sufficient for mediating specific interaction with ubiquitin and
the kinase-like domain is also involved in ubiquitin binding.
We also tested OspG and ubiquitin interaction in eukaryotic
host cells. Transient expression of OspG into 293T cells could
efficiently co-immunoprecipitate endogenous ubiquitin (Fig. 3E).
In contrast, mutation of the carboxyl-terminal two leucine residues
(L190D/L191D) in OspG abolished the interaction in this
transfection assay (Fig. 3E). To confirm this interaction during
Shigella infection, an ospG deletion strain of S. flexneri was
constructed. A Flag-tagged OspG was transformed into the
deletion strain and infection was then performed. As shown in
Fig. 3F, Flag-OspG expressed in the bacteria could co-immuno-
precipitate endogenous ubiquitin from infected 293T cells, and
importantly the L190D/L191D mutant was also defective in
interacting with ubiquitin in this infection assay. As another
control, OspG expressed in the type III secretion deficient DmxiH
strain did not co-immunoprecipitate ubiquitin from infected 293T
cells (Fig. 3F). These data demonstrate the type III-delivered
OspG can bind to host ubiquitin and the interaction also requires
the carboxyl terminal helical region in OspG.
OspG and OspG-like Effectors are a Type of Atypical
Serine/threonine Kinases
OspG shows sequence similarity to eukaryotic protein serine/
threonine kinase [24]. A typical serine/threonine kinase domain
can be divided into eleven sub-domains (I-VI, VIIA, VIIB, VIII-
XI) [29,30]. Aligning the sequence of OspG to the kinase domain
of a prototypical eukaryotic serine/threonine kinase JNK3 shows
that residues from 24 to 160 of OspG are homologous to JNK3
kinase sub-domains I-VII (Fig. 4). The predicted secondary
structures of OspG can also be aligned well to those of JNK3
sub-domains I-VII, and all the catalytically important residues
within these domains are maintained in OspG (Fig. 4). However,
OspG apparently lacks the kinase sub-domains VIII–XI (Fig. 4).
The sub-domain VIII is the activation loop whose conformational
change usually stimulates the kinase activity upon serine/
threonine phosphorylation of this loop by an upstream kinase or
itself [29]. The sub-domains IX and X are generally required for
maintaining the overall structural integrity [29]. Thus, OspG
appears to be a half kinase with all necessary catalytic residues.
Given that no physiological substrates of OspG have been
reported, we performed the kinase assay by using a generic
artificial substrate myelin basic protein (MBP) and examined both
MBP phosphorylation and OspG autophosphorylation either in
the absence or presence of ubiquitin. While no MBP phosphor-
ylation was detected, phosphorylation of GST-OspG by itself was
observed (Fig. 5A), which confirms the observation made in the
previous study [24]. Given that the autophosphorylation signal is
rather weak, we further purified MBP-OspG and His6-OspG and
assayed their autophosphorylation activity. Interestingly, no
autophosphorylation occurred on MBP-OspG and His6-OspG
(data not shown). Through mass spectrometry analysis, the
autophosphorylation site of GST-OspG was mapped to a serine
residue located in the linker region between the GST and OspG
(Fig. S1A). This observation not only explains why no ‘‘autopho-
sphorylation’’ occurred on MBP-OspG and His6-OspG, but also
indicates that the observed ‘‘autophosphorylation’’ of GST-OspG
differs from the classical kinase autophosphorylation that usually
occurs on the activation loop. To confirm the kinase activity of
OspG, we then assayed two other commercially available artificial
substrates, casein from bovine milk and histone from calf thymus.
While no phosphorylation of casein was observed, an evident
phosphorylation signal was detected in the crude histone extract
(Fig. S1B). Taken together, these data provide definitive experi-
mental evidences for the kinase activity of recombinant OspG
protein.
OspG has homologous effector proteins in other bacterial
pathogens, including NleH1/2 in EPEC and enterohaemorrhagic
E. coli (EHEC), and NleH in the mouse pathogen Citrobacter
rodentium, which are all closely related diarrheagenic pathogens.
OspG and NleHs share evident sequence similarities within the
kinase domain (also sub-domains I-VII only) (Fig. S2A). In
addition, NleH1/2 bears an extended N-terminal region that lacks
the similarity to OspG. GST-NleH1 and GST-NleH2 could also
phosphorylate themselves (Fig. S2B), similarly to that observed
with GST-OspG. However, when the catalytic lysine residue
important for ATP binding was mutated to alanine, no autopho-
sphorylation of GST-NleH1/2 could be detected [31] (Fig. S2B).
These results confirm that OspG and OspG-like bacterial effectors
harbor serine/threonine kinase activity in vitro.
Ubiquitin Binding Stimulates the Kinase Activity of OspG
OspG binds to free ubiquitin, poly-ubiquitin chains and even
ubiquitin-conjugated proteins. It is intuitively difficult to imagine
that the function of OspG is to target host ubiquitin signaling as we
hypothesized originally. Given that several type III effectors
require binding to abundant host factors for their own activation,
we then hypothesize that OspG may use ubiquitin binding to
modulate its own biochemical activity, i.e. the kinase activity. Most
notably, addition of ubiquitin into the phosphorylation reaction
drastically promoted GST-OspG autophosphorylation (Fig. 5A) as
well as phosphorylation of the crude histone extract (Fig. S1B).
This ubiquitin-stimulated auto-phosphorylation was completely
abolished when the serine residue in the linker region was mutated
into alanine (Fig. 5B), suggesting a similar nature of autopho-
sphorylation upon ubiquitin stimulation. Lys-53 of OspG is the
predicted catalytic residue that anchors and orients the ATP, and
Asp-138 is the potential catalytic residue to accept the proton from
the attacking hydroxyl group. When these two residues were
individually mutated toAla, autophosphorylation of GST-OspG
was undetectable even in the presence of ubiquitin (Fig. 5C). This
excludes the possibility that phosphorylation of GST-OspG comes
from a contamination activity. In contrast to wild-type ubiquitin,
ubiquitin I44A mutant or other UBL proteins did not stimulate the
autophosphorylation of GST-OspG (Fig. 5D), which is consistent
with their deficient binding to OspG. Similarly to ubiquitin, both
the beads. (B and C) Pulldown of OpsG by K48- or K63-linked poly-ubiquitin chains. Ni-NTA Sepharose beads coated with His6-ubiquitin chains with
indicated linkages were incubated with GST or GST-OspG. Proteins retained on the beads were subjected to SDS-PAGE and anti-GST immunoblotting
analysis. (D) Pulldown of free ubiquitin by GST-OspG. GST or GST-OspG proteins were immobilized onto Glutathione Sepharose beads and the beads
were then incubated with lysates of 293T cells. The interacting proteins eluted from the beads were resolved by 4–20% gradient SDS-PAGE gel and
analyzed by anti-ubiquitin immunoblotting.
doi:10.1371/journal.pone.0057558.g001
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PLOS ONE | www.plosone.org 4 February 2013 | Volume 8 | Issue 2 | e57558Figure 2. OspG directly and specifically binds to free ubiquitin. (A) Pulldown of free ubiquitin by OspG. His6-OspG was immobilized onto Ni-
NTA beads and the beads were then incubated with GST, GST-ubiquitin, GST-ubiquitin I44A mutant, GST-LC3 or GST-SUMO1. Bound proteins were
eluted from the beads and resolved on the SDS-PAGE gel followed by Coomassie blue staining. (B and C) Complex formation of ubiquitin and OspG
on the gel filtration column. Purified Flag-His6-ubiquitin and His6-OspG proteins were subjected to Superdex-75 gel filtration chromatography
individually or after being mixed together. Shown in (B) are the chromatograms. Aliquots of indicated fractions were resolved on the SDS-PAGE gel
stained with Coomassie blue in (C).
doi:10.1371/journal.pone.0057558.g002
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PLOS ONE | www.plosone.org 5 February 2013 | Volume 8 | Issue 2 | e57558Figure 3. The carboxyl terminus of OspG is required for interaction with ubiquitin. (A) Schematic presentation of OspG truncations
assayed in (B-D). The gray box donates the region that shows sequence similarity to eukaryotic serine/threonine kinase sub-domains I-VII. (B, C and
D) Pulldown assays of the binding between ubiquitin and various OspG truncation proteins. Ni-NTA Sepharose beads coated with His6-ubiquitin
were incubated with GST, GST-OspG or indicated GST-OspG truncation proteins. Proteins retained on the beads were eluted and then subjected to
SDS-PAGE and Coomassie blue staining analysis. (E) Coimmunoprecipitation assay of OspG (WT or L190D/L191D mutant) and ubiquitin interaction in
transfected HEK 293T cells. Shown are immunoblots of anti-Flag immunoprecipitates (Flag IP) and total cell lysates (Input). (F) Assay of OspG and
ubiquitin interaction during Shigella infection. HEK 293T cells were infected with indicated Shigella deletion/complementation strains. Lysates of
infected cell were subjected to anti-Flag immunoprecipitation. DmxiH is a type III secretion deficient strain; pME6032 is a rescue plasmid for
expressing Flag-OspG (wild-type or L190D/L191D mutant) in the bacteria. Shown are immunoblots of anti-Flag immunoprecipitates (Flag IP) and total
cell lysates (Input).
doi:10.1371/journal.pone.0057558.g003
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autophosphorylation of GST-OspG (Fig. 5E). Deletion of the
carboxyl terminal 26 residues from OspG that resulted in
a defective ubiquitin binding severely attenuated the phosphory-
lation of GST-OspG (Fig. 5F). Similarly, autophosphorylation of
GST-OspG L190D/L191D double mutant was not responsive to
ubiquitin stimulation (Fig. 5F). Moreover, ubiquitin addition did
not promote the autophosphorylation of GST-NleH1/2 (Fig.
S2B), which is consistent with their lack of a carboxyl terminal
sequence required for ubiquitin binding in OspG (Fig. S2A). In all
above kinase assays, phosphorylation of ubiquitin was never
observed (Fig. 5A). These data strongly support the hypothesis that
ubiquitin is not a target of OspG but instead regulates the kinase
activity of OspG.
Some kinases have been demonstrated to have intrinsic ATPase
activity [32,33,34,35]. When His6-OspG was incubated with ATP
and the phosphate release was detected by molybdate dye/
phosphate complex formation, OspG exhibited intrinsic ATPase
activity, which was also significantly increased by addition of
ubiquitin (Fig. 5G). As expected, ubiquitin alone did not promote
phosphate release from ATP. This again confirms our hypothesis
that ubiquitin binding functions to stimulate the biochemical
activity of OspG when it is translocated into host cells.
Ubiquitin Binding is Required for the Function of OspG in
Attenuating Host NF-kB Signaling during Infection
Ubiquitin or ubiquitin-chain decoration of intracellular bacteria
has been proposed as a signal that triggers autophagy-mediated
host defense. To probe the functional consequence of OspG
ubiquitin binding and activation of its kinase activity during Shigella
infection, we first checked whether OspG plays a role in ubiquitin-
chain formation surrounding intracellular Shigella. Using an
antibody specific for polyubiquitinated proteins (FK1), we were
able to detect some polyubiquitin signals around a portion of
intracellular S. flexneri in infected HeLa cells, but this effect was not
affected by deletion of ospG from the bacteria (Fig. 6A). This
suggests that OspG does not play a role in recruitment or
generation of polyubiquitinated proteins around S. flexneri during
infection. Previous study suggests that OspG may interfere with
the innate immune NF-kB signaling in S. flexneri-infected host cells
[24]. Confirming this observation, TNFa treatment induced
a more rapid degradation of IkBa inhibitory protein in HeLa
cells infected with the DospG strain compared with that in wild-
type strain (Fig. 6B). While re-expression of wild-type OspG in the
deletion strain restored the inhibition of TNFa-induced IkBa
degradation, the ubiquitin binding-deficient L190D/L191D mu-
tant of OspG failed to complement the deletion strain in blocking
IkBa degradation (Fig. 6B). These results suggest that OspG
requires binding to host ubiquitin to exert its function in
suppressing host innate immune signaling, which is likely through
activation of its kinase activity.
Discussion
In summary, we have discovered that Shigella type III effector
OspG directly and specifically interacts with host ubiquitin
through the I44 hydrophobic patch on the ubiquitin surface.
OspG also binds to poly-ubiquitin chains and ubiquitin-conjugat-
ed proteins. Binding to ubiquitin stimulates the kinase and intrinsic
ATP hydrolysis activity of OspG, which, as an atypical kinase,
exhibits sequence similarity to eukaryotic serine/threonine kinase
sub-domains I-VII. Our data suggest a novel mechanism of
activating a bacterial virulence effector by the host ubiquitin
system. Our data also demonstrate that OspG and OspG-like
effectors, NleHs from EPEC/EHEC, are atypical kinases and do
exhibit in vitro kinase activity. It is important for future studies to
identify the host target or kinase substrate of OspG, which shall
advance our understanding of OspG binding to ubiquitin as well
as its functional role in Shigella pathogenesis. Shigella secrets the
IpaH family of ubiquitin ligase effectors and the OspI effector that
targets host Ubc13 for deamidation. Therefore, ubiquitin binding
and activation of OspG provides an additional layer of complexity
to the interplay between Shigella and the eukaryotic ubiquitin
Figure 4. Secondary structure-based sequence alignment of OspG with human JNK3. The protein names are indicated at the left of the
alignment. The key residues in the kinase domain are colored in red. Predicted secondary structures of OspG are shown on top of the OspG sequence.
Secondary structures determined from crystal structure of JNK3 are shown underneath the sequence of JNK3 in the alignment. Green ovals are
a helices and blue arrows are b strands. The sub-domains are labeled with Roman numerals.
doi:10.1371/journal.pone.0057558.g004
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PLOS ONE | www.plosone.org 7 February 2013 | Volume 8 | Issue 2 | e57558Figure 5. Ubiquitin binding stimulates the autophosphorylation and ATP hydrolysis activity of OspG. (A) Kinase assay of OspG in the
presence or absence of ubiquitin. Purified OspG protein was incubated with [c-P
32] ATP with or without the addition of ubiquitin into the reaction.
Myelin basic protein (MBP) was included as the possible artificial substrate. Incorporation of phosphate into the protein was examined by
autoradiography of the reaction mixtures resolved on the SDS-PAGE gel as shown. (B) Effects of mutation in the autophosphorylation site of GST-
OspG. The autophosphorylated serine residue in the linker region of GST-OspG was mutated into alanine and the mutant protein (S/A) was subjected
to the kinase assay in the presence or absence of ubiquitin as described in (A). (C) Effects of mutations in the putative catalytic residues on ubiquitin
stimulation of OspG kinase activity. Wild-type or indicated mutant GST-OspG (K53A and D138A) proteins were used for the autophosphorylation
assay in the presence or absence of ubiquitin. Autophosphorylation of OspG is shown by autoradiography in the upper panel. Coomassie blue
staining of GST-OspG proteins are shown in the lower panel. (D) Autophosphorylation assay of GST-OspG in the presence of GST-tagged ubiquitin,
ubiquitin I44A, LC3 or SUMO1. (E) Autophosphorylation assay of GST-OspG in the presence of free ubiquitin, K48- or K63-linked poly-ubiquitin chains.
(F) Autophosphorylation assay of GST-OspG, GST-OspG DN23, GST-OspG DC26 or GST-OspG L190D/L191D mutant. The assays were all performed in
the presence of ubiquitin. (G) ATP hydrolysis assay of OspG and effects of addition of ubiquitin. His6-OspG and ubiquitin were incubated together
with or without ATP supplementation. Release of the phosphate following the reaction was detected by measuring the phospho-molybdate complex
formation on a spectrometer (absorbance at 600 nm).
doi:10.1371/journal.pone.0057558.g005
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related to the ubiquitin system or not.
The activity of bacterial virulence effectors is often under tight
and sophisticated regulation, through which the bacteria can
manipulate host processes efficiently and effectively. Turning on
the biochemical activity of bacterial type III effectors by binding to
host factors have been shown for several other effectors in recent
studies. The canonical Yersinia serine/threonine kinase effector
YpkA has a low or undetectable kinase activity in the bacteria,
which is significantly stimulated by actin binding to its extreme
carboxyl terminal region [36]. Another type III effector AvrRpt2
from plant pathogen Pseudomonas syringae binds to plant cyclophilin
protein to turn on its cysteine protease activity [37]. An extensively
studied Yersinia type III effector YopJ harbors an O-acetyltransfer-
ase activity that is promoted by host small molecule inositol
hexakisphosphate (IP6) [38]. All these effectors appear to bind to
a rather abundant host factor for activation, and this feature also
applies to OspG as ubiquitin is one of the most abundant proteins
in eukaryotic cells. A general assumption for host activation of
bacterial virulence factors is that bacteria, in this way, can prevent
effector activities that might be harmful to themselves. This could
be the case for the three characterized effectors mentioned above.
However, due to the fact that OspG lacks the kinase activation
loop as well as the kinase sub-domains VIII–XI, it is also possible
that requiring of binding to a host factor for OspG activation
might result from the intrinsic structural property of OspG and
OspG-like atypical kinase effectors. This further predicts the
presence of other distinct host factors that are required for
activation of OspG-like NleHs effectors from EPEC/EHEC.
Figure 6. Ubiquitin binding of OspG is required for inhibiting host NF-kB signaling during Shigella infection. (A) The role of OspG in
recruitment of ubiquitin to intracellular Shigella. HeLa cells were infected with wild type (WT) or DospG mutant S. flexneri strain. Polyubiquitinated
proteins stained by the FK1 antibody (green), intracellular bacteria stained by anti-Shigella antibody (red) and DAPI-stained nuclei (blue) were
visualized by fluorescence microscopy. (B) The role of OspG ubiquitin binding activity in inhibiting NF-kB activation in Shigella-infected cells. HeLa
cells were infected with indicated S. flexneri strains. Infected cells were treated with TNFa to stimulate NF-kB pathway activation. Lysates of infected
cell collected at indicated time points after the stimulation were subjected to anti-IkBa and anti-tubulin immunoblotting analyses.
doi:10.1371/journal.pone.0057558.g006
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Plasmids and Reagents
OspG gene was PCR amplified from the Shigella flexneri 2a strain
301. For recombinant expression in E. coli, OspG was constructed
into pGEX-6P-2 and pET21a vectors. cDNAs for ubiquitin,
SUMO1 and LC3 were also subcloned into pGEX-6p-2 to
generate GST fusion proteins. Point mutations were generated by
the QuikChange site-directed mutagenesis kit (Stratagene). All of
the plasmids were verified by DNA sequencing. His6-tagged poly-
ubiquitin chains (K48-linked and K63-linked) were purchased
from Boston Biochem. Anti-GST (sc-138) and anti-ubiquitin
(P4D1, sc-8017) antibodies were from Santa Cruz Biotechnology.
Artificial kinase substrates casein from bovine milk and histone
from calf thymus were both purchased from Sigma.
Protein Expression and Purification
All recombinant proteins were expressed and purified from E.
coli BL21 (DE3) strain. Protein expression was induced at room
temperature (RT) with 0.4 mM isopropyl-b-D-thiogalactopyrano-
side (IPTG) for 12 hours when OD600 reached 0.6. Cells were
harvested and re-suspended in the lysis buffer containing 25 mM
HEPES (pH 7.4) and 150 mM NaCl. Cells were lysed by
sonication, and the debris was pelleted at 16,000 rpm for 60
minutes. The supernatant was then applied to the corresponding
resins for affinity purification. The GST fusion protein was
purified by using glutathione-Sepharose resin (GE Healthcare).
The His6-tagged fusion protein was purified by using Ni-NTA
resin (Qiagen).The resins were washed with the lysis buffer and
then eluted with glutathione or immidazole-containing buffer.
Eluted proteins were dialyzed against the lysis buffer, concentrated
and stored in 20% glycerol at 220uC. Concentrations of purified
recombinant proteins were determined by Coomassie blue staining
of SDS-PAGE gels using the BSA standards.
Cell Culture and Immunoprecipitation
HEK 293T cells obtained from ATCC were grown in DMEM
(Hyclone) supplemented with 10% fetal bovine serum (Gibco) and
2 mM L-glutamine (Hyclone) at 37uC in a 5% CO2 incubator. To
prepare the cell extracts, approximately 1610
7 cells were washed
once with PBS and re-suspended in 1 ml of the lysis buffer
(25 mM HEPES, pH 7.4,150 mM NaCl,1 mM DTT, and 1%
Triton X-100). The cell lysates were placed on ice for 15 minute
and then spun at 13,000 rpm for 15 minute to collect the
supernatant. To block proteasomal degradation, cells were treated
with 5 mM MG132 for 3 hours prior to lysis. For immunoprecip-
itation, 293T cells were transiently transfected with Flag-HA-
OspG (wild type or indicated mutants). After 24 hours, cells were
washed with PBS and lysed for 15 min in a buffer containing
50 mM HEPES (pH 7.4), 150 mM NaCl, and 1% Triton X-
100.The lysates were cleared by centrifugation and proteins were
immunoprecipitated with anti-Flag M2 beads (Sigma). The
immunoprecipitates were washed four times with the lysis buffer
and subjected to immunoblotting analysis.
Pulldown and Analytical gel-filtration Binding Assays
For the pulldown assay, , 2 mg of proteins were immobilized
on Ni-NTA or glutathione-Sepharose resins and the resins were
then incubated with 20 mg of prey proteins in 1 mL of binding
buffer (25 mM HEPES, pH7.4, 150 mM NaCl, 1% Triton X-100)
at 4uC for one hour. The resins were then centrifuged and
extensively washed with the binding buffer. Proteins retained on
the resins were eluted with an SDS loading buffer (50 mM Tris-
HCl, pH6.8, 2% SDS, 10% glycerol, and 100 mM DTT).
To analyze complex formation on the gel filtration column,
200 mg of His6-OspG (23.6 kDa) and 100 mg of Flag-His6-
ubiquitin (12.1 kDa) proteins were loaded onto the 24-ml Super-
dex 75 10/300 column (GE Healthcare) individually or after they
were pre-mixed. The column buffer for chromatography contains
25 mM HEPES, pH 7.4, 150 mM NaCl and 1 mM DTT.
Fractions of 300 ml each were collected. Aliquots of every other
fraction were subjected to SDS-PAGE and Coomassie blue
staining analysis.
Kinase and ATP Hydrolysis Assays
2 mg of OspG or GST-OspG were incubated with 2 mCi of [c-
P
32] ATP in the kinase assay buffer containing 10 mM HEPES,
pH 7.4,10 mM MgCl2 and 10 mM cold ATP at 30uC for 30
minutes.1 mg of ubiquitin and myelin basic protein (MBP) were
added into the reaction as indicated. The reactions were quenched
with the SDS loading buffer, loaded onto a 15% SDS-PAGE gel
and transferred to a PVDF membrane (Millipore). Radioactivity
was analyzed by autoradiography.
The ATPase activity of His6-OspG was determined by
measuring the release of the inorganic phosphate. The reaction
was carried out at 30uC for 30 minutes in a buffer containing
25 mM HEPES (pH 7.4), 150 mM NaCl, 10 mM MgCl2, and
0.5 mM ATP. The reaction was initiated by addition of purified
OspG, and quenched by adding 50 ml of molybdate dye/additive
mixture (Promega). Following color development, the released
inorganic phosphates were measured at the absorbance of
600 nm.
Genetic Manipulation of Shigella and Infection Assays
In-frame deletion of ospG from Shigella flexneri 2a 2457T was
performed as previously described [11]. For infection, cultures of
indicated Shigella strains were added to HeLa cells at MOI of 100
followed by centrifugation at 800 g for 10 min at RT to facilitate
bacterial attachment. Infection was performed at 37uC for one
hour, and the cells were then washed with PBS and incubated for
additional four hours in fresh culture medium supplemented
100 ug/ml gentamicin to kill the extracellular bacteria. To
examine ubiquitin recruitment to the bacteria, infected cells were
fixed and subjected to immunofluorescence analysis. Bacteria were
stained with anti-Shigella antibody (Abcam) and the polyubiquiti-
nated proteins were stained with FK1 antibody (Millipore). To
assay IkBa degradation, infected cells were treated with 10 ng/mL
TNFa for indicated time periods. The cells were then lysed in 2X
Laemmli buffer, and the protein samples were loaded onto an
SDS-PAGE gel for immunoblotting analysis. For complementa-
tion in DospG strain, 1 mM IPTG was added to the culture
medium to induce OspG expression. To test OspG-ubiquitin
interaction, HEK 293T cells were infected with indicated Shigella
strains harboring Flag-OspG expression plasmid (the Flag tag was
inserted into OspG after Asn-17) at MOI of 100 for five hours.
Cells were lysed in a buffer containing 25 mM HEPES (pH 7.4),
150 mM NaCl and 0.1% Triton X-100. Cell lysates were cleared
by centrifugation and then subjected to anti-Flag immunoprecip-
itation.
Supporting Information
Figure S1 Autophosphorylation site in GST-OspG and
kinase assay of OspG. (A) Shown is the amino acid sequence of
recombinant GST-OspG protein used in the kinase assay and
subjected to mass spectrometry analysis. Residues in red
correspond to the tryptic peptide sequence identified by mass
spectrometry analysis. The sequence of OspG is underlined. The
Ubiquitin Binding Activates OspG Kinase Activity
PLOS ONE | www.plosone.org 10 February 2013 | Volume 8 | Issue 2 | e57558serine residue identified as the phosphorylation site is shown on
a blue background. (B) OspG kinase assay using commercial
histones as the artificial substrates. The assay was performed in the
absence or presence of ubiquitin.
(TIF)
Figure S2 Ubiquitin does not stimulate the kinase
activity of OspG-like effector NleH1/2. (A) Sequence
alignment of Shigella flexneri OspG with NleH1/2 from entero-
pathogenic Escherichia coli O55:H7 (strain CB9615). The protein
names are listed on the left of the alignment. Conserved residues
are marked in pink, and similar residues are shown in green. (B)
The kinase assay of GST-NleH1 (WT and K159A mutant) and
GST-NleH2 (WT and K169A mutant) in the absence or presence
of ubiquitin.
(TIF)
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